查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830966

血管成形术球囊市场

Angioplasty Balloons Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

血管成形术球囊市场预计将从 2024 年的 29 亿美元成长到 2031 年的 37.2 亿美元，在 2025 年至 2031 年期间实现 3.6% 的复合年增长率。

市场洞察与分析师视角：血管成形术球囊市场的预测为利害关係人制定成长策略提供了宝贵的见解。本报告概述了预测期内的成长机会、市场趋势及其预期影响。

血管成形术是一种旨在扩张狭窄或阻塞的冠状动脉以恢復血流的手术。价值导向型医疗的转变，强调成本效益和病人预后，正在改变医疗保健格局。血管成形术球囊市场将取决于这些设备与其他疗法相比，能够改善患者预后、降低血管重建率并降低成本的能力。与传统手术方法相比，血管成形术球囊提供了一种治疗阻塞动脉的微创方法。由于患者和医疗保健提供者都青睐微创治疗方案，对血管成形术球囊的需求正在成长。心血管疾病发生率的上升以及对微创手术的日益青睐，正在推动血管成形术球囊市场的扩张。然而，与血管成形术相关的併发症可能会阻碍市场成长。

成长动力：心血管疾病发病率上升推动血管成形术球囊市场发展世界卫生组织 (WHO) 将心血管疾病确定为全球发病率和死亡率的主要原因。这些疾病包括脑血管疾病、冠状动脉心臟病和风湿性心臟病。导致心血管疾病的主要生活方式因素包括吸烟、不良饮食和缺乏体能活动。美国心臟协会报告称，2020 年心血管疾病相关死亡人数从 2019 年的 874,613 人上升至 928,741 人。在美国，冠状动脉心臟病占 2020 年心血管疾病死亡人数的 41.2%，其次是中风（17.3%）、高血压（12.9%）、心臟衰竭（9.2%）、动脉疾病（2.6%）和其他心血管疾病（16.8%）。世界心臟联盟预计，到 2030 年，每年将有超过 2,300 万人死于心血管疾病。

此外，心血管危险因子在中欧和西欧普遍存在，这主要是由于吸烟和高酒精消费率，尤其是在男性中。每年有超过400万欧洲人死于心血管疾病，主要为冠状动脉疾病和中风。中东地区的心血管疾病发生率也很高，因此需要采取各种干预措施，例如健康教育、生活方式咨询、筛检和治疗。根据世界心臟联盟的数据，心血管疾病是中东和北非地区的主要死因，占所有死亡人数的三分之一以上，每年死亡人数达140万人。因此，心血管疾病盛行率的上升是血管成形术球囊市场成长的重要驱动力。

虽然血管成形术通常被认为是安全的，但据报道，手术期间或术后可能会出现併发症。风险包括血栓、心律不整、血管或心臟瓣膜损伤、中风、对支架材料或药物洗脱支架的过敏反应、支架内再狭窄或支架内部阻塞。其中一些风险可能危及生命，并且在某些情况下，例如心臟病发作期间，患者可能没有足够的时间接受血管成形术。这些併发症可能会阻碍血管成形术球囊市场的成长。

策略洞察报告细分和范围：透过检查以下细分来分析血管成形术球囊市场：类型、应用和最终用户。

細項分析：依类型划分，血管成形术球囊市场分为普通球囊、药物洗脱球囊、切割球囊及刻划球囊。普通球囊在2022年占据了最大的市场。然而，预计药物洗脱球囊在2022年至2030年期间的复合年增长率最高。

根据应用，血管成形术球囊市场分为週边血管成形术球囊和冠状动脉血管成形术球囊。 2022年，冠状动脉血管成形术球囊占据了更大的市场份额，预计在2022-2030年期间将呈现最高的复合年增长率，这得益于冠状动脉疾病（尤其是心臟病）发病率的上升。根据美国疾病管制与预防中心 (CDC) 2023年3月的更新数据，冠心病是最常见的心臟病类型，在20岁及以上的人群中，约有1/20的人患有此病。然而，预计週边血管成形术球囊在2022-2030年期间将实现更高的复合年增长率。

根据最终用户，血管成形术球囊市场细分为医院、门诊手术中心和导管室。医院市场在2022年占据最大市场份额，预计在2022年至2030年期间的复合年增长率最高。

区域分析：血管成形术球囊市场报告的地理范围涵盖北美、欧洲、亚太地区、中东和非洲以及南美和中美。 2022年，北美占据了最大的市场份额，其成长动力包括人口老化负担加重、产品上市数量增加以及持续研发先进血管成形术球囊的努力。

血管成形术球囊市场报告范围、竞争格局和重点公司：血管成形术球囊市场报告中介绍的重点公司包括雅培、波士顿科学公司、康德乐、库克医疗、CR Bard Inc、ENDOCOR GmbH、美敦力、Spectranetics、BIOTRONIK 和 Terumo Medical Corporation。这些公司专注于开发新技术、改进现有产品并扩大其地理覆盖范围，以满足日益增长的全球需求。近期的关键发展包括：

2023年3月，SIS Medical AG在美国推出了采用TWIN-Wall技术的OPN NC PTCA扩张导管，该导管性能卓越、安全性高，且成功率远超其他球囊。 OPN NC导管采用TWIN-Wall设计，可提供卓越的耐压性能，额定爆破压力高达35个大气压力，且顺应性显着降低。 2022年9月，Advanced NanoTherapies公司凭藉其用于治疗冠状动脉疾病的SirPlux Duo药物涂层球囊(DCB)获得美国食品药品监督管理局(FDA)的突破性医疗器材认证(BDD)。 SirPlux Duo DCB能够低剂量、长期释放两种化合物来抑制细胞生长，达到超越任何其他DCB或药物洗脱支架的最大药效。 2022年1月，Scoreflex NC Scoring PTCA导管获得美国食品药物管理局(FDA)的上市前核准(PMA)。 Scoreflex NC 是一种评分 PTCA 导管，用于治疗冠状动脉缺血患者的冠状动脉新发狭窄部分和支架内再狭窄，旨在改善心肌灌注。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：血管成形术球囊市场概况

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：血管成形术球囊市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：血管成形术球囊市场－全球市场分析

  • 血管成形术球囊 - 全球市场概览
  • 血管成形术球囊－全球市场及2030年预测

第七章：血管成形术球囊市场-收入分析-按类型，2020-2030

  • 概述
  • 普通气球
  • 药物洗脱球囊
  • 得分气球
  • 切割气球

第 8 章：血管成形术球囊市场 - 收入分析 - 按应用，2020-2030 年

  • 概述
  • 冠状动脉
  • 週边设备

第 9 章：血管成形术球囊市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院
  • 门诊手术中心
  • 心导管实验室

第 10 章：血管成形术球囊市场 - 收入分析，2020-2030 年 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：血管成形术球囊市场 - 主要公司简介

  • Abbott
  • Boston Scientific Corporation
  • Cardinal Health
  • Cook Medical
  • BD (C. R. Bard, Inc.)
  • ENDOCOR GmbH
  • Medtronic
  • Spectranetics
  • BIOTRONIK
  • Terumo Medical Corporation

第 14 章：附录

简介目录
Product Code: TIPHE100001278

The angioplasty balloons market is expected to increase from US$ 2.90 billion in 2024 to US$ 3.72 billion by 2031, achieving a CAGR of 3.6% during the period from 2025 to 2031.

Market Insights and Analyst Perspective:The forecast for the angioplasty balloons market provides valuable insights for stakeholders to strategize their growth. This report outlines growth opportunities, market trends, and their anticipated effects throughout the forecast period.

Angioplasty is a procedure aimed at widening narrowed or blocked coronary arteries to restore blood flow. The shift towards value-based care, which emphasizes cost-effectiveness and patient outcomes, is transforming the healthcare landscape. The angioplasty balloons market will be shaped by the ability of these devices to enhance patient outcomes, lower revascularization rates, and reduce costs compared to alternative treatments. Angioplasty balloons offer a less invasive approach to treating blocked arteries compared to traditional surgical methods. The demand for angioplasty balloons is increasing as both patients and healthcare providers favor less invasive options. The growing incidence of cardiovascular diseases and the rising preference for minimally invasive procedures are driving the expansion of the angioplasty balloons market. However, complications related to angioplasty may hinder market growth.

Growth Drivers:Rising Incidence of Cardiovascular Diseases Fuels Angioplasty Balloons Market

The World Health Organization (WHO) identifies cardiovascular diseases as the leading cause of morbidity and mortality globally. These diseases encompass cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Key lifestyle factors contributing to cardiovascular diseases include tobacco use, poor diet, and lack of physical activity. The American Heart Association reported that cardiovascular disease-related deaths rose to 928,741 in 2020, up from 874,613 in 2019. In the US, coronary heart disease accounted for 41.2% of cardiovascular disease deaths in 2020, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), arterial diseases (2.6%), and other cardiovascular conditions (16.8%). The World Heart Federation anticipates over 23 million deaths annually due to cardiovascular diseases by 2030.

Additionally, cardiovascular risk factors are prevalent in Central and Western Europe, largely due to smoking and high alcohol consumption rates, particularly among men. Over 4 million Europeans die each year from cardiovascular diseases, primarily from coronary artery disease and stroke. The Middle East also experiences a high prevalence of cardiovascular diseases, necessitating various interventions such as health education, lifestyle counseling, screening, and treatment. According to the World Heart Federation, cardiovascular disease is the leading cause of death in the Middle East & North Africa, responsible for over a third of all deaths, totaling 1.4 million annually. Therefore, the increasing prevalence of cardiovascular diseases is a significant driver of growth in the angioplasty balloons market.

While angioplasty procedures are generally considered safe, there are reported complications that can arise during or after the surgery. Risks include blood clots, irregular heartbeats, damage to blood vessels or heart valves, strokes, allergic reactions to stent materials or drug-eluting stents, in-stent restenosis, or blockage of the stent's interior. Some of these risks can be life-threatening, and in certain situations, patients may not have sufficient time to undergo angioplasty, such as during a heart attack. These complications can impede the growth of the angioplasty balloons market.

Strategic Insights

Report Segmentation and Scope:The analysis of the angioplasty balloons market has been conducted by examining the following segments: type, application, and end user.

Segmental Analysis:In terms of type, the angioplasty balloons market is categorized into normal balloons, drug-eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug-eluting balloons segment is projected to exhibit the highest CAGR from 2022 to 2030.

By application, the angioplasty balloons market is divided into peripheral and coronary segments. The coronary segment accounted for a larger share of the angioplasty balloons market in 2022 and is expected to show the highest CAGR during 2022-2030, driven by the rising incidence of coronary artery diseases, particularly heart disease. According to a March 2023 update from the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most common type of heart disease, affecting about 1 in 20 individuals aged 20 and older. Nevertheless, the peripheral segment is anticipated to achieve a higher CAGR during 2022-2030.

Based on end user, the angioplasty balloons market is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest market share in 2022 and is expected to register the highest CAGR from 2022 to 2030.

Regional Analysis:The geographic scope of the angioplasty balloons market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2022, with growth driven by the increasing burden of an aging population, a rising number of product launches, and ongoing R&D efforts to develop advanced angioplasty balloons.

Angioplasty Balloons Market Report Scope

Competitive Landscape and Key Companies:Key companies profiled in the angioplasty balloons market report include Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation. These companies are focused on developing new technologies, enhancing existing products, and expanding their geographic reach to meet the growing global demand. Recent key developments include:

In March 2023, SIS Medical AG launched the OPN NC PTCA Dilatation Catheter with TWIN-Wall technology in the US, offering superior performance and safety with success rates where other balloons fail. The OPN NC catheter features a TWIN-Wall design that provides exceptional pressure resistance with a rated burst pressure of 35 atm and significantly low compliance.

In September 2022, Advanced NanoTherapies received Breakthrough Device Designation (BDD) from the FDA for its SirPlux Duo Drug-Coated Balloon (DCB) aimed at treating coronary artery disease. The SirPlux Duo DCB delivers a low-dose, long-term release of both compounds to inhibit cell growth, achieving maximum potency that surpasses any other DCB or drug-eluting stent.

In January 2022, the Scoreflex NC Scoring PTCA Catheter obtained Premarket Approval (PMA) from the US FDA. The Scoreflex NC is a scoring PTCA catheter indicated for the treatment of de novo stenotic portions of coronary arteries and in-stent restenosis in patients with coronary ischemia, aimed at improving myocardial perfusion.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Angioplasty Balloon Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Angioplasty Balloon Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Angioplasty Balloon Market - Global Market Analysis

  • 6.1 Angioplasty Balloon - Global Market Overview
  • 6.2 Angioplasty Balloon - Global Market and Forecast to 2030

7. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Normal Balloons
  • 7.3 Drug Eluting Balloons
  • 7.4 Scoring Balloons
  • 7.5 Cutting Balloon

8. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Coronary
  • 8.3 Peripheral

9. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Cath Labs

10. Angioplasty Balloon Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Angioplasty Balloon Market Overview
    • 10.1.2 North America Angioplasty Balloon Market Revenue and Forecasts to 2030
    • 10.1.3 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Material
    • 10.1.5 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Application
    • 10.1.6 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By End User
    • 10.1.7 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.7.1 United States Angioplasty Balloon Market
        • 10.1.7.1.1 United States Angioplasty Balloon Market, by Type
        • 10.1.7.1.2 United States Angioplasty Balloon Market, by Material
        • 10.1.7.1.3 United States Angioplasty Balloon Market, by Application
        • 10.1.7.1.4 United States Angioplasty Balloon Market, by End User
      • 10.1.7.2 Canada Angioplasty Balloon Market
        • 10.1.7.2.1 Canada Angioplasty Balloon Market, by Type
        • 10.1.7.2.2 Canada Angioplasty Balloon Market, by Material
        • 10.1.7.2.3 Canada Angioplasty Balloon Market, by Application
        • 10.1.7.2.4 Canada Angioplasty Balloon Market, by End User
      • 10.1.7.3 Mexico Angioplasty Balloon Market
        • 10.1.7.3.1 Mexico Angioplasty Balloon Market, by Type
        • 10.1.7.3.2 Mexico Angioplasty Balloon Market, by Material
        • 10.1.7.3.3 Mexico Angioplasty Balloon Market, by Application
        • 10.1.7.3.4 Mexico Angioplasty Balloon Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Angioplasty Balloon Market - Key Company Profiles

  • 13.1 Abbott
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Boston Scientific Corporation
  • 13.3 Cardinal Health
  • 13.4 Cook Medical
  • 13.5 BD (C. R. Bard, Inc.)
  • 13.6 ENDOCOR GmbH
  • 13.7 Medtronic
  • 13.8 Spectranetics
  • 13.9 BIOTRONIK
  • 13.10 Terumo Medical Corporation

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud